Business Context and Reporting Period
This Form 8-K is a current report filed by OncoCyte Corporation (trading symbol: OCX) on June 24, 2021. The filing serves as a Regulation FD disclosure regarding a presentation delivered at the company's 2021 Annual Meeting of Shareholders. The presentation covered corporate development, strategic plans, and other matters, with the specific content furnished as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice of a shareholder presentation rather than a financial statement. Investors must refer to the company's Annual Report on Form 10-K or the attached Exhibit 99.1 slides for detailed financial data.
Material Changes
No material financial changes or comparative period data are disclosed within the text of this Form 8-K. The filing focuses solely on the dissemination of information presented to shareholders on the date of the report.
Guidance, Outlook, and Risks
- Management Commentary: The company presented information on corporate development and future plans to shareholders.
- Forward-Looking Statements: The filing includes a standard disclaimer that statements containing words such as "may," "will," "believes," and "expects" are forward-looking. Actual results may differ materially due to various factors.
- Risks: Specific risk factors are not detailed in this text but are referenced as being contained in the company's Annual Report on Form 10-K under the heading "Risk Factors."
- Unusual Items: No unusual items or contingencies are described in the body of this report.
Important Facts for Investor Verification
- Verify the specific content of the shareholder presentation by reviewing Exhibit 99.1 attached to this filing.
- Confirm that the registrant is OncoCyte Corporation, noting the discrepancy with the user-provided company name "Insight Molecular Diagnostics Inc."
- Review the Form 10-K for detailed financial metrics and risk factors, as this 8-K does not contain them.
- Note that the information in Item 7.01 and Exhibit 99.1 is deemed "furnished" and not "filed" for liability purposes under Section 18 of the Exchange Act.